<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-biomolecules-10-01625">
 <label>50.</label>
 <element-citation publication-type="gov">
  <person-group person-group-type="author">
   <collab>US National Library of Medicine</collab>
  </person-group>
  <article-title>A Representative Example of the Development of MLN4924 for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03772925" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT03772925</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-11-20">(accessed on 20 November 2020)</date-in-citation>
 </element-citation>
</ref>
